Survival in primary pulmonary hypertension. Validation of a prognostic equation.

BACKGROUND The prognosis of patients with primary pulmonary hypertension (PPH) remains a major problem for the planning and assessment of therapeutic interventions. The objectives of this study were (1) to characterize mortality in a Mexican population of patients with PPH and to investigate factors associated with survival and (2) to test the applicability in this population of the prognostic equation proposed by the US National Institutes of Health study on PPH. METHODS AND RESULTS A dynamic cohort of patients with PPH at our institution were enrolled between June 1977 and August 1991 and prospectively followed at regular intervals through September 1992. Measurements at diagnosis included hemodynamic and pulmonary function variables in addition to information on demographic data and medical history. The response to vasodilator treatment was also analyzed. The estimated median survival of the group was 4.04 years (95% confidence interval, 2.98 to 5.08 years). Variables associated with poor survival (univariate analysis) included an elevated mean right atrial pressure, a decreased cardiac index, and a decreased mixed venous PO2. A reduced forced vital capacity and the absence of vasodilator treatment were also associated with poor survival. A multivariate Cox proportional-hazards regression analysis was used to assess the adjusted hazard ratios, hence the relative contributions of the variables controlling for confounding. Reduced forced vital capacity and cardiac index and increased right atrial pressure were still significantly associated as risk factors for survival in patients with PPH. Survival as computed by the equation correlated with real survival of PPH patients with positive predictive values of 87%, 91%, and 89% at 1, 2, and 3 years, respectively. The equation, however, was relatively unable to predict deaths in our population, in part because of the strict limits of poor prognosis. CONCLUSIONS Mortality in PPH is largely associated with hemodynamic variables that assess right ventricular function. The proposed prognostic equation had a high sensitivity and a relatively low specificity to predict survival in our PPH population. To improve this specificity it may be necessary to increase the limits of poor prognosis as defined by the equation.

[1]  J. Matloff,et al.  Single lung transplantation for primary pulmonary hypertension , 1996 .

[2]  S. Rich,et al.  The effect of high doses of calcium-channel blockers on survival in primary pulmonary hypertension. , 1992, The New England journal of medicine.

[3]  J. Loscalzo.  Endothelial dysfunction in pulmonary hypertension. , 1992, The New England journal of medicine.

[4]  B. Groves,et al.  The acute administration of vasodilators in primary pulmonary hypertension. Experience from the National Institutes of Health Registry on Primary Pulmonary Hypertension. , 1989, The American review of respiratory disease.

[5]  H. Palevsky,et al.  Classification of Histologic Lesions in Primary Pulmonary Hypertension Group Medial lesions Intimal lesions Medial hypertrophy Increased smooth muscle , 2005 .

[6]  B. Brundage,et al.  Pulmonary hypertension: a cellular basis for understanding the pathophysiology and treatment. , 1989, Journal of the American College of Cardiology.

[7]  J. C. Ross,et al.  Primary pulmonary hypertension: a look at the future. , 1989, Journal of the American College of Cardiology.

[8]  D. Fitchett,et al.  Vasodilators and pulmonary arterial hypertension: the paradox of therapeutic success and clinical failure. , 1988, International journal of cardiology.

[9]  L. Rubin,et al.  Prostacyclin and PGE1 treatment of pulmonary hypertension. , 1987, The American review of respiratory disease.

[10]  N. Kanemoto.  Natural history of pulmonary hemodynamics in primary pulmonary hypertension. , 1987, American heart journal.

[11]  E H Bergofsky,et al.  Primary pulmonary hypertension. A national prospective study. , 1987, Annals of internal medicine.

[12]  E. Robin,et al.  PRIMARY PULMONARY HYPERTENSION , 2022 .

[13]  B. Brundage,et al.  Antinuclear antibodies in primary pulmonary hypertension. , 1986, Journal of the American College of Cardiology.

[14]  B. Brundage,et al.  Primary pulmonary hypertension: radiographic and scintigraphic patterns of histologic subtypes. , 1986, Annals of internal medicine.

[15]  L. Rubin,et al.  Primary Pulmonary Hypertension: AN ANALYSIS OF 28 CASES AND A REVIEW OF THE LITERATURE , 1986 .

[16]  R. Soulen.  Primary Pulmonary Hypertension: A Histopathologic Study of 80 Cases , 1985 .

[17]  V. Fuster,et al.  Primary pulmonary hypertension: natural history and the importance of thrombosis. , 1984, Circulation.

[18]  S. Rich,et al.  Characteristics of surviving and nonsurviving patients with primary pulmonary hypertension. , 1984, The American journal of medicine.

[19]  K. Rosen,et al.  Reassessment of the effects of vasodilator drugs in primary pulmonary hypertension: guidelines for determining a pulmonary vasodilator response. , 1983, American heart journal.

[20]  E. Lupi-Herrera,et al.  The Role of Hydralazine Therapy for Pulmonary Arterial Hypertension of Unknown Cause , 1982, Circulation.

[21]  M. Rabinovitch,et al.  A case of spontaneous resolution of idiopathic pulmonary hypertension. , 1981, British heart journal.

[22]  E. Lupi-Herrera,et al.  The role of isoproterenol in pulmonary artery hypertension of unknown etiology (primary): short- and long-term evaluation. , 1981, Chest.

[23]  C. Wagenvoort.  Lung biopsy specimens in the evaluation of pulmonary vascular disease. , 1980, Chest.

[24]  J. S. Bower,et al.  Mechanisms of gas exchange abnormality in patients with chronic obliterative pulmonary vascular disease. , 1979, The Journal of clinical investigation.

[25]  H. Sasamoto,et al.  Pulmonary hemodynamics in primary pulmonary hypertension. , 1979, Japanese heart journal.

[26]  C. Oakley,et al.  Regression of primary pulmonary hypertension. , 1976, British heart journal.

[27]  Carlos A. Dumont,et al.  A radiologic index of pulmonary arterial hypertension. , 1975, Chest.

[28]  E. Trell.  Benign, idiopathic pulmonary hypertension? Two further cases of unusually long duration. , 2009, Acta medica Scandinavica.

[29]  C. Wagenvoort,et al.  Primary Pulmonary Hypertension: A Pathologic Study of the Lung Vessels in 156 Clinically Diagnosed Cases , 1970 .

[30]  A. Charters,et al.  Primary pulmonary hypertension of unusually long duration. , 1970, British heart journal.

[31]  G. M. Solov'ev,et al.  [Primary pulmonary hypertension]. , 1961, Terapevticheskii arkhiv.

[32]  D. Dresdale,et al.  Primary pulmonary hypertension. I. Clinical and hemodynamic study. , 1951, The American journal of medicine.